Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani, MA Salehi, A Heidari… - European cytokine …, 2020 - Springer
Abstract Coronavirus disease (COVID-19) reached pandemic proportions at the beginning
of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory …
被引用次数：52 相关文章

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani, MA Salehi, A Heidari… - European Cytokine …, 2020 - jle.com
Coronavirus disease (COVID-19) reached pandemic proportions at the beginning of 2020
and continues to be a worldwide concern. End organ damage and acute respiratory distress …

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani, MA Salehi… - European Cytokine …, 2020 - pure.uj.ac.za
Abstract Coronavirus disease (COVID-19) reached pandemic proportions at the beginning
of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory …
[HTML] nih.gov

[HTML][HTML] Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani, MA Salehi… - European Cytokine …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease (COVID-19) reached pandemic proportions at the beginning
of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory …

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani… - European …, 2020 - researchexperts.utmb.edu
Abstract Coronavirus disease (COVID-19) reached pandemic proportions at the beginning
of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory …

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani, MA Salehi… - European …, 2020 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease (COVID-19) reached pandemic proportions at the beginning of 2020
and continues to be a worldwide concern. End organ damage and acute respiratory distress …
[PDF] researchgate.net

[PDF][PDF] Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani, MA Salehi… - Eur. Cytokine …, 2020 - researchgate.net
Coronavirus disease (COVID-19) reached pandemic proportions at the beginning of 2020
and continues to be a worldwide concern. End organ damage and acute respiratory distress …

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality.

N Moradian, M Gouravani, MA Salehi… - European Cytokine …, 2020 - europepmc.org
Abstract Coronavirus disease (COVID-19) reached pandemic proportions at the beginning
of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory …

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality.

N Moradian, M Gouravani, MA Salehi… - European Cytokine …, 2020 - europepmc.org
Abstract Coronavirus disease (COVID-19) reached pandemic proportions at the beginning
of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory …

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani, MA Salehi, A Heidari… - European Cytokine …, 2020 - jle.com
IL-1β production and signaling pathways. When certain cells are activated, IL-1β's
production is induced, resulting in activation of caspase 1 and the production of the activated …